NewslettersProstate Cell NewsUncategorizedAntitumor Activity and Molecular Mechanism of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) InhibitionBy Justin.choi - March 25, 20220183Scientists discuss the advancement of PCSK9 research on its role and underlying mechanisms in tumor development and progression.[Naunyn-Schmiedebergs Archives of Pharmacology] 6445212 AAAAAAAA items 1 apa 0 default asc 1 173281 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract